Browsing by Author Amariles, P

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
1-Oct-2010Clinical value of blood pressure measurement in the community pharmacySabater-Hernández, D; Azpilicueta, I; Sánchez-Villegas, P; Amariles, P; Baena, MI; Faus, MJ
Jan-2008Efecto del Metodo Dader de Seguimiento Farmacoterapéutico en el riesgo cardiovascular de pacientes con factores de riesgo o enfermedad cardiovascular (EMDADER-CV): Metodos y resultados globalesAmariles, P; Faus, MJ; Jimenez- Martin, J; Sabater Hernandez, D; Garcia-Jimenez, E
1-Jan-2012Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trialAmariles, P; Sabater-Hernández, D; García-Jiménez, E; Rodríguez-Chamorro, MA; Prats-Más, R; Marín-Magán, F; Galán-Ceballos, JA; Jiménez-Martín, J; José Faus, M
1-Oct-2015Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomesOcampo, CC; Garcia-Cardenas, V; Martinez-Martinez, F; Benrimoj, SI; Amariles, P; Gastelurrutia, MA
1-Aug-2011Magnitude of the white-coat effect in the community pharmacy setting: The MEPAFAR studySabater-Hernández, D; De La Sierra, A; Sánchez-Villegas, P; Baena, MI; Amariles, P; Faus, MJ
1-Jun-2011Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR studySabater-Hernández, D; Sánchez-Villegas, P; García-Corpas, JP; Amariles, P; Sendra-Lillo, J; Faus, MJ
1-Nov-2016Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmaciesAmariles, P; Pino-Marín, D; Sabater-Hernández, D; García-Jiménez, E; Roig-Sánchez, I; Faus, MJ